About P3 protein
P3 protein (SLC10A3) is a protein
from Homo sapiens identified by UniProt accession
P09131, 477 residues long.
MolForge cross-references it against 0 known binders and
30 disease associations.
Target properties
| Protein name | P3 protein |
| UniProt accession | P09131 |
| Gene | SLC10A3 |
| Organism | Homo sapiens |
| Length | 477 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (30)
Diseases linked to this target (Open Targets).
- hemoglobin measurement · score 0.11
- mean corpuscular volume · score 0.11
- hematocrit · score 0.11
- hypertriglyceridemia 2 · score 0.08
- cholesterol-ester transfer protein deficiency · score 0.07
- Combined hyperlipidemia · score 0.06
- thyroid hormone metabolism, abnormal, 2 · score 0.06
- sitosterolemia · score 0.05
- homozygous familial hypercholesterolemia · score 0.05
- neoplasm · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P09131-F1 | alphafold | PREDICTED | 76.76 | — |
Amino-acid sequence (477 residues)
MVLMQDKGSS QQWPGLGGEG GGTGPLSMLR AALLLISLPW GAQGTASTSL STAGGHTVPP TGGRYLSIGD GSVMEFEFPE DSEGIIVISS QYPGQANRTA PGPMLRVTSL DTEVLTIKNV SAITWGGGGG FVVSIHSGLA GLAPLHIQLV DAHEAPPTLI EERRDFCIKV SPAEDTPATL SADLAHFSEN PILYLLLPLI FVNKCSFGCK VELEVLKGLM QSPQPMLLGL LGQFLVMPLY AFLMAKVFML PKALALGLII TCSSPGGGGS YLFSLLLGGD VTLAISMTFL STVAATGFLP LSSAIYSRLL SIHETLHVPI SKILGTLLFI AIPIAVGVLI KSKLPKFSQL LLQVVKPFSF VLLLGGLFLA YRMGVFILAG IRLPIVLVGI TVPLVGLLVG YCLATCLKLP VAQRRTVSIE VGVQNSLLAL AMLQLSLRRL QADYASQAPF IVALSGTSEM LALVIGHFIY SSLFPVP
Explore P3 protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets